Key points are not available for this paper at this time.
This article reviews recommended strategies for screening and treatment of latent tuberculosis in the United States, with attention to the role of interferon-γ–release assays in screening and of shorter treatment regimens (as compared with a 9-month course of isoniazid).
Horsburgh et al. (Wed,) studied this question.